サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562240

アジア太平洋の近視治療：2030年市場予測-地域別分析-タイプ別、治療法別、年齢層別、エンドユーザー別

Asia Pacific Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User

出版日
ページ情報
英文 107 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.41円
アジア太平洋の近視治療：2030年市場予測-地域別分析-タイプ別、治療法別、年齢層別、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 107 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の近視治療市場は、2022年に30億9,716万米ドルと評価され、2030年には63億4,864万米ドルに達すると予測され、2022年から2030年までのCAGRは9.4%と推定されます。

対象となる近視を治療するための先端技術の利用可能性の高まりがアジア太平洋の近視治療市場を押し上げる

対象となる近視を治療するための先端技術の利用可能性が高まっていることは、近視治療市場にとって大きなチャンスです。レーザー補助原位角膜切開術（LASIK）、光屈折角膜切除術（PRK）、および有水晶体眼内レンズ（ICL）などの技術の進歩により、近視をより効果的に、そして合併症が少ない形で矯正することが可能になりました。Johnson & Johnson Visionの支援を受けた30以上の演題が発表に承認されました。外科医は革新的なSILK（i.e., Smooth Incision Lenticule Keratomileusis）治療を乱視のある近視患者の治療に適用することができ、またELITATMプラットフォームを利用することもできます。ELITATMプラットフォームは、その高速レーザー照射技術と超精密レーザーパルスにより、翌日の治療結果と回復を伴う、非常にスムーズで簡便なレンズ嚢切除術を外科医に提供します。このような高度な技術は、従来は高価で、多くの患者には手が届きませんでした。しかし、これらの技術がより広く利用されるようになれば、近視治療市場が拡大し、より多くの患者に優れた治療オプションを提供するチャンスとなります。これらの先端技術に加え、オルソケラトロジー（オルソK）やアトロピン点眼薬などの新たな治療法も、近視を管理する効果的な方法として人気を集めています。人気のあるオルソケラトロジー用コンタクトレンズは、最新のクーパービジョンの近視抑制製品であり、CEマークを取得しました。この製品は、EyeDreamやParagon CRTのオルソケラトロジーデザイン、MiSightのデイソフトコンタクトレンズ、SightGlass Visionの拡散光学技術メガネレンズに加わります。これらの非侵襲的治療は、外科的治療よりも手頃な価格であるため、より幅広い患者が利用しやすくなっています。全体として、対象となる近視を治療するための先進技術の利用可能性が高まっていることは、近視治療市場に大きな機会をもたらしています。患者により効果的で利用しやすい治療オプションを提供することで、市場は視力の健康状態を改善し、世界のヘルスケア状況における重要なアンメットニーズに対応することができます。

アジア太平洋の近視治療市場概要

アジア太平洋の近視治療市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。この地域は、2022年にアジア太平洋の近視治療市場の30.14%以上を占めましたが、これはこの地域における高齢化人口の増加、調査研究の増加、政府支援の増加、眼関連疾患の増加によるものです。

アジア太平洋では、中国が2022年のアジア太平洋の近視治療市場で最大の市場シェアを占めました。市場成長の主な要因は、人口の高齢化、近視の有病率の増加、予防医療の重視の高まりです。例えば、人口問題研究所が2020年に発表した調査によると、中国の老齢人口は2050年までに3億6,600万人に達すると予想されています。さらに、同じ推計によると、中国の人口の約26％が2050年までに65歳以上になり、2020年の12％から増加します。このような老年人口の大幅な増加は、同国における製品需要の増加に有利な機会を提供すると予想されます。また、中国では近視の有病率、特に子供の近視の有病率が大幅に増加しており、中国での治療法の採用が増加する可能性が高いです。例えば、British Journal of Ophthalmologyによると、2019年の中国の未就学児と小中学生の近視有病率は50.2％でした。さらに、同じ情報源によると、2021年には6歳から16歳までの子供と青少年の54.71％が全体的に近視でした。このように、老年人口の増加と近視の有病率の増加が市場成長の原動力となっています。

アジア太平洋の近視治療市場の収益と2030年までの予測（金額）

アジア太平洋の近視治療市場セグメンテーション

アジア太平洋の近視治療市場は、タイプ、治療法、年齢層、エンドユーザー、国に分類されます。

タイプ別では、アジア太平洋の近視治療市場は、強度近視、変性近視、進行性近視に区分されます。2022年のアジア太平洋の近視治療市場シェアは、強度近視分野が最大でした。

治療に関しては、アジア太平洋の近視治療市場は低用量アトロピン点眼薬、コンタクトレンズ、オルソケラトロジー、屈折矯正手術に区分されます。低用量アトロピン点眼薬セグメントは、2022年にアジア太平洋の近視治療市場で最大のシェアを占めました。さらに、屈折矯正手術セグメントはレーシックとPRKに細分化されます。

年齢層別では、アジア太平洋の近視治療市場は成人近視と小児近視に二分されます。成人近視セグメントは、2022年のアジア太平洋の近視治療市場においてより大きなシェアを占めています。

エンドユーザーに基づき、アジア太平洋の近視治療市場は病院・クリニック、専門クリニック、屈折矯正手術センターに分類されます。2022年のアジア太平洋の近視治療市場シェアは、病院・クリニックセグメントが最大でした。

国別では、アジア太平洋の近視治療市場はオーストラリア、中国、日本、インド、韓国、その他アジア太平洋地域に分類されます。2022年のアジア太平洋の近視治療市場シェアは中国が独占しました。

Bausch Health Companies Inc、Alcon AG、CooperVision Inc、Johnson &Johnson Vision Care Inc、Nidek Co Ltd、Haag-Streit AG、Carl Zeiss AGは、アジア太平洋の近視治療市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の近視治療市場情勢

  • PEST分析
  • 企業シェア分析

第5章 アジア太平洋の近視治療市場：主要市場力学

  • アジア太平洋の近視治療市場- 主な市場力学
  • 市場促進要因
    • 近視の有病率の上昇
    • 近視治療に対する意識の高まり
  • 市場抑制要因
    • 熟練した専門家の不足
  • 市場機会
    • ターゲットとする近視を治療するための先端技術の利用可能性の増加
  • 今後の動向
    • 近視治療における人工知能の応用
  • 促進要因と抑制要因の影響

第6章 近視治療市場-アジア太平洋市場分析

第7章 アジア太平洋の近視治療市場分析：タイプ別

  • 強度近視
  • 変性近視
  • 進行性近視

第8章 アジア太平洋の近視治療市場分析：治療法別

  • 低用量アトロピン点眼薬
  • 屈折矯正手術
  • コンタクトレンズ
  • オルソケラトロジー

第9章 アジア太平洋の近視治療市場分析：年齢層別

  • 成人近視
  • 小児近視

第10章 アジア太平洋の近視治療市場分析：エンドユーザー別

  • 病院・クリニック
  • 専門クリニック
  • 屈折矯正手術センター

第11章 アジア太平洋の近視治療市場：国別分析

  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域

第12章 業界情勢

  • 近視治療市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 成長戦略

第13章 企業プロファイル

  • Bausch Health Companies Inc
  • Alcon AG
  • CooperVision Inc
  • Johnson & Johnson Vision Care Inc
  • Nidek Co Ltd
  • Haag-Streit AG
  • Carl Zeiss AG

第14章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Myopia Treatment Market Segmentation
  • Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
  • Table 3. Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 4. Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 5. Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 6. Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 7. Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 8. China: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 9. China: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 10. China: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 11. China: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 12. China: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 13. Japan: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 14. Japan: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 15. Japan: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 16. Japan: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 17. Japan: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 18. India: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 19. India: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 20. India: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 21. India: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 22. India: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 23. Australia: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 24. Australia: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 25. Australia: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 26. Australia: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 27. Australia: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 28. South Korea: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 29. South Korea: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 30. South Korea: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 31. South Korea: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 32. South Korea: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 33. Rest of Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 34. Rest of Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 35. Rest of Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 36. Rest of Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 37. Rest of Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 38. Recent Organic Growth Strategies in Myopia Treatment Market
  • Table 39. Recent Inorganic Growth Strategies in the Myopia Treatment Market
  • Table 40. Glossary of Terms, Myopia Treatment Market

List Of Figures

  • Figure 1. Asia Pacific Myopia Treatment Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Myopia Treatment Market Revenue (US$ Million), 2020-2030
  • Figure 5. Asia Pacific Myopia Treatment Market Share (%) - by Type (2022 and 2030)
  • Figure 6. High Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Degenerative Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Progressive Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Asia Pacific Myopia Treatment Market Share (%) - by Treatment (2022 and 2030)
  • Figure 10. Low-Dose Atropine Eye Drops: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Refractive Surgery: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. LASIK: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. PRK: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Contact Lenses: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Ortho-K: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific Myopia Treatment Market Share (%) - by Age Group (2022 and 2030)
  • Figure 17. Adult Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Childhood Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific Myopia Treatment Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Hospitals and Clinics: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Refractive Surgery Centers: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Asia Pacific: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 25. China: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Japan: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. India: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Australia: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. South Korea: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Rest of Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Growth Strategies in Myopia Treatment Market
目次
Product Code: BMIRE00030373

The Asia Pacific myopia treatment market was valued at US$ 3,097.16 million in 2022 and is expected to reach US$ 6,348.64 million by 2030; it is estimated to register a CAGR of 9.4% from 2022 to 2030.

Rising Availability of Advanced Technologies for Treating the Targeted Myopia Boosts Asia Pacific Myopia Treatment Market

The rising availability of advanced technologies for treating targeted myopia is a significant opportunity for the myopia treatment market. Advances in technologies such as laser-assisted in-situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and implantable collamer lenses (ICL) have made it possible to correct myopia more effectively and with fewer complications. Various ground-breaking data were also presented during the congress; over 30 abstracts backed by Johnson & Johnson Vision have been approved for presentation. Surgeons can apply the innovative SILK (i.e., Smooth Incision Lenticule Keratomileusis) treatment to treat myopic patients who have astigmatism or do not utilize the ELITATM Platform. The ELITATM Platform offers surgeons an exceptionally smooth and uncomplicated lenticular removal procedure with next-day outcomes and recovery owing to its fast laser delivery technology and ultra-precise laser pulse. These advanced technologies have traditionally been expensive and inaccessible to many patients. Still, as they become more widely available, they present an opportunity for the myopia treatment market to expand its reach and provide better treatment options to a larger patient population. In addition to these advanced technologies, other emerging treatments such as orthokeratology (ortho-k) and atropine eye drops are gaining popularity as effective methods for managing myopia. The popular orthokeratology contact lens is the latest CooperVision myopia control product to gain the CE Mark, joining EyeDream and Paragon CRT ortho-k designs, MiSight day soft contact lenses, and SightGlass Vision Diffusion Optics Technology spectacle lenses. These non-invasive treatments can be more affordable than surgical options, making them accessible to a wider range of patients. Overall, the rising availability of advanced technologies for treating targeted myopia presents a significant opportunity for the myopia treatment market. By providing patients with more effective and accessible treatment options, the market can help improve vision health outcomes and address a significant unmet need in the global healthcare landscape.

Asia Pacific Myopia Treatment Market Overview

Asia Pacific myopia treatment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. This region accounted for over 30.14% of the Asia Pacific myopia treatment market in 2022 owing to the increasing aging population, rising number of research studies, growing government support, and increasing eye-related disorders in the region.

In Asia Pacific, China held the largest market share for Asia Pacific myopia treatment market in 2022. The market growth is primarily attributed to the aging population, the increasing prevalence of myopia, and the rising emphasis on preventive care. For instance, according to a study published by the Population Reference Bureau in 2020, the old-age population of China is expected to reach ~366 million by 2050. Moreover, according to the same estimates, around 26% of China's population will be over 65 by 2050, up from 12% in 2020. Such an extensively increasing geriatric population is anticipated to offer lucrative opportunities for the increased demand for products in the country. The country is also witnessing considerable growth in the prevalence of myopia, particularly in children, which is likely to increase the adoption of treatments in China. For instance, preschoolers and primary and secondary school students in China had a 50.2% prevalence of myopia in 2019, according to the British Journal of Ophthalmology. Additionally, according to the same source, 54.71% of children and adolescents between the ages of 6 and 16 had myopia overall in 2021. Thus, the increasing geriatric population and the increasing prevalence of myopia are driving the market growth.

Asia Pacific Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Myopia Treatment Market Segmentation

The Asia Pacific myopia treatment market is categorized into type, treatment, age group, end user, and country.

Based on type, the Asia Pacific myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest Asia Pacific myopia treatment market share in 2022.

In terms of treatment, the Asia Pacific myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest Asia Pacific myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the Asia Pacific myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger Asia Pacific myopia treatment market share in 2022.

Based on end user, the Asia Pacific myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest Asia Pacific myopia treatment market share in 2022.

Based on country, the Asia Pacific myopia treatment market is categorized into Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific myopia treatment market share in 2022.

Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Nidek Co Ltd, Haag-Streit AG, and Carl Zeiss AG are some of the leading companies operating in the Asia Pacific myopia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Myopia Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Market Share Analysis, By Companies

5. Asia Pacific Myopia Treatment Market - Key Market Dynamics

  • 5.1 Asia Pacific Myopia Treatment Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Myopia
    • 5.2.2 Increased Awareness of Myopia Treatment
  • 5.3 Market Restraints
    • 5.3.1 Lack of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Rising Availability of Advanced Technologies for Treating The Targeted Myopia
  • 5.5 Future Trends
    • 5.5.1 Application of Artificial Intelligence in Myopia Treatment
  • 5.6 Impact of Drivers and Restraints:

6. Myopia Treatment Market - Asia Pacific Market Analysis

7. Asia Pacific Myopia Treatment Market Analysis - by Type

  • 7.1 High Myopia
    • 7.1.1 Overview
    • 7.1.2 High Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Degenerative Myopia
    • 7.2.1 Overview
    • 7.2.2 Degenerative Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Progressive Myopia
    • 7.3.1 Overview
    • 7.3.2 Progressive Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Myopia Treatment Market Analysis - by Treatment

  • 8.1 Low-Dose Atropine Eye Drops
    • 8.1.1 Overview
    • 8.1.2 Low-Dose Atropine Eye Drops: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Refractive Surgery
    • 8.2.1 Overview
    • 8.2.2 Refractive Surgery: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.2.3 LASIK
    • 8.2.4 PRK
  • 8.3 Contact Lenses
    • 8.3.1 Overview
    • 8.3.2 Contact Lenses: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Ortho-K
    • 8.4.1 Overview
    • 8.4.2 Ortho-K: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Myopia Treatment Market Analysis - by Age Group

  • 9.1 Adult Myopia
    • 9.1.1 Overview
    • 9.1.2 Adult Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Childhood Myopia
    • 9.2.1 Overview
    • 9.2.2 Childhood Myopia: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Myopia Treatment Market Analysis - by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Overview
    • 10.1.2 Hospitals and Clinics: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Specialty Clinics
    • 10.2.1 Overview
    • 10.2.2 Specialty Clinics: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Refractive Surgery Centers
    • 10.3.1 Overview
    • 10.3.2 Refractive Surgery Centers: Asia Pacific Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Myopia Treatment Market - Country Analysis

  • 11.1 Asia Pacific
    • 11.1.1 Asia Pacific: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Asia Pacific: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 China
      • 11.1.1.3 China: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 China: Myopia Treatment Market Breakdown, by Type
        • 11.1.1.3.2 China: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.1.3.3 China: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.1.3.4 China: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.1.3.5 China: Myopia Treatment Market Breakdown, by End User
      • 11.1.1.4 Japan
      • 11.1.1.5 Japan: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Japan: Myopia Treatment Market Breakdown, by Type
        • 11.1.1.5.2 Japan: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.1.5.3 Japan: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.1.5.4 Japan: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.1.5.5 Japan: Myopia Treatment Market Breakdown, by End User
      • 11.1.1.6 India
      • 11.1.1.7 India: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 India: Myopia Treatment Market Breakdown, by Type
        • 11.1.1.7.2 India: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.1.7.3 India: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.1.7.4 India: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.1.7.5 India: Myopia Treatment Market Breakdown, by End User
      • 11.1.1.8 Australia
      • 11.1.1.9 Australia: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.9.1 Australia: Myopia Treatment Market Breakdown, by Type
        • 11.1.1.9.2 Australia: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.1.9.3 Australia: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.1.9.4 Australia: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.1.9.5 Australia: Myopia Treatment Market Breakdown, by End User
      • 11.1.1.10 South Korea
      • 11.1.1.11 South Korea: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.11.1 South Korea: Myopia Treatment Market Breakdown, by Type
        • 11.1.1.11.2 South Korea: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.1.11.3 South Korea: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.1.11.4 South Korea: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.1.11.5 South Korea: Myopia Treatment Market Breakdown, by End User
      • 11.1.1.12 Rest of Asia Pacific
      • 11.1.1.13 Rest of Asia Pacific: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.13.1 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by Type
        • 11.1.1.13.2 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.1.13.3 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.1.13.4 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.1.13.5 Rest of Asia Pacific: Myopia Treatment Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Myopia Treatment Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Bausch Health Companies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Alcon AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 CooperVision Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Johnson & Johnson Vision Care Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Nidek Co Ltd
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Haag-Streit AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Carl Zeiss AG
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms